Shire Pharmaceuticals Acquires SARCode Bioscience for $160,000,000

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=92d4b8f2-1f09-4a03-84e2-76785e461005&Preview=1
Date
3/26/2013
Company Name
SARCode Bioscience
Mailing Address
1000 Marina Boulevard Brisbane, CA 94005
Company Description
SARcode is a private company focused on the development of small molecule LFA-1 inhibitors to treat inflammatory diseases.
Website
http://www.sarcode.com
Transaction Type
M&A
Transaction Amount
$160,000,000
Transaction Round
Proceeds Purposes
M&A Terms
In addition to the upfront payment of $160 million, shareholders in California-based SARcode will be eligible for additional undisclosed payments upon achievement of certain drug development and commercial milestones.